CYCLODEXTRINE ALS PROCOAGULANTEN

European patent · EP3448395 · In force

Register entry

Publication number
EP3448395
Application number
EP17727407
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 1, 2017
Published
Mar 6, 2019
Granted
Apr 22, 2020
Protection ends at the latest
Apr 30, 2037
Next annual fee due
May 31, 2026
IPC classes
A61K 31/724 (2006.01)
A61K 45/06 (2006.01)
A61K 38/58 (2006.01)
A61K 31/4439 (2006.01)
A61K 31/444 (2006.01)
A61K 31/4545 (2006.01)
A61K 31/5377 (2006.01)
A61K 31/727 (2006.01)
A61K 31/737 (2006.01)
C08B 37/16 (2006.01)
A61P 7/04 (2006.01)
Priority
EP 16167738 29.04.2016
PCT application
PCT/NL2017/050275 01.05.2017
PCT publication
WO2017/188820 02.11.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  2. Jun 2, 2024

    Change

    Published in Swissreg on 02.06.2024

  3. Jun 2, 2023

    Change

    Published in Swissreg on 02.06.2023

  4. Apr 22, 2020

    Granted

    Published in Swissreg on 22.04.2020

Parties

Inventor

ZOLLINGER, Daniel Philipp

6534 AT Nijmegen, NL

BAKHTIARI, Kamran

1066 CX Amsterdam, NL

PETERS, Stephan Leonard Maria

6534 AT Nijmegen, NL

MEIJERS, Josephus Cornelis Maria

1066 CX Amsterdam, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.